Hypercoagulability, high tissue factor and low tissue factor pathway inhibitor levels in severe ovarian hyperstimulation syndrome: possible association with clinical outcome-Reference-Cited by-同舟云学术

Hypercoagulability, high tissue factor and low tissue factor pathway inhibitor levels in severe ovarian hyperstimulation syndrome: possible association with clinical outcome

Published:2003-04 Issue:3 Volume:14 Page:277-282
ISSN:0957-5235
Container-title:Blood Coagulation & Fibrinolysis
language:en
Short-container-title:Blood Coagulation & Fibrinolysis

Author:

Rogolino Angela,Coccia Maria Elisabetta,Fedi Sandra,Gori Anna Maria,Cellai Anna Paola,Scarselli Gian Franco,Prisco Domenico,Abbate Rosanna

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Hematology,General Medicine

Reference45 articles.

1. The ovarian hyperstimulation syndrome

2. Prevention and treatment of ovarian hyperstimulation

3. Internal jugular vein thrombosis in association with the ovarian hyperstimulation syndrome

4. Internal jugular vein thrombosis after ovarian stimulation: Case report

5. Interleukin-2 and ovarian hyperstimulation syndrome: a pilot study

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Retrospective analysis on clinical characteristics and venous thromboembolism outcomes using bridging prophylaxis with low molecular weight heparin for thrombophilic women performing oocyte retrieval for assisted reproductive procedures: 15 years of experience;Italian Journal of Medicine;2024-06-17

2. Ovarian Hyperstimulation Syndrome;Updates in Intensive Care of OBGY Patients;2024

3. Venous Thromboembolism in Pregnancy: Challenges and Solutions;Vascular Health and Risk Management;2023-07

4. Peripheral blood transcriptome analysis of patients with ovarian hyperstimulation syndrome through high-throughput sequencing;Reproductive and Developmental Medicine;2023-01-03

5. Coagulation and Fibrinolysis Biomarkers as Potential Indicators for the Diagnosis and Classification of Ovarian Hyperstimulation Syndrome;Frontiers in Medicine;2021-08-25